Advanced Enzyme Technologies Limited

Human Healthcare (68%)
The company provides proprietary enzyme products and customized enzyme solutions to various pharmaceutical and nutraceutical companies in India, North America, Asia (ex-India), Europe, and other countries globally.

Animal Nutrition (11%)
It provides enzyme-based feed additives for the animal nutrition industry, mainly catering to poultry and swine. Animal Nutrition product offering enables animals to maximize the nutrients they absorb from the feed which helps the customers to reduce the feed costs.

Industrial Bioprocessing (15%)
The company produces non-food processing enzymes for various industries such as textiles, leather, detergent, and pulp & paper, which are used in the manufacturing of a wide range of products. It also produces food processing enzymes which are essential for enhancing food and beverage products.

Specialized Manufacturing (6%)
In this segment, the Co. manufactures products based on effervescent technology. These effervescent products extend solutions in Nutraceutical, Pharmaceutical, Bakery, Washing solutions, and other Speciality products.

International Presence
Co. is present in 45+ countries and caters to 700+ customers worldwide.
9MFY24
India - 50%
Americas - 33%
Europe - 6%
Asia (Excluding India) - 7%
Rest of the World - 4%

Manufacturing Facilities
The company owns and operates 9 manufacturing facilities which includes 7 in India and 2 in the USA. The company has a 500 m³ fermentation capacity from its manufacturing facilities.

R&D Capabilities
The company operates 7 R&D facilities, 5 are located in India, 1 in the USA, and 1 in Germany.
The company planning to set up a new R&D facility at an estimated cost of Rs 70-80 crore in next three fiscals.

Intellectual Property
The company has 13 patents, 400+ proprietary products, 13 Food Enzyme Dossiers filed with EFSA, 7 GRAS Dossier
evaluated by US FDA.

Investment
In Feb,24, the company acquired an additional stake of 5.89% in its subsidiary JC Biotech Private Limited for ~Rs. 5.6. crs. This increased the equity stake held to 95.72%.